Literature DB >> 1972774

Role of intracellular Ca2+ mobilization in muscarinic and histamine receptor-mediated activation of guanylate cyclase in N1E-115 neuroblastoma cells: assessment of the arachidonic acid release hypothesis.

W Surichamorn1, C Forray, E E el-Fakahany.   

Abstract

This study evaluates the role of intracellular levels of Ca2+ [Ca2+]i in cyclic GMP formation mediated by muscarinic and histamine receptors in the mouse neuroblastoma clone N1E-115. Muscarinic agonists activated the turnover of phosphoinositides with a relative maximal response similar to that observed previously for cyclic GMP formation. Carbamylcholine induced a transient increase in inositol trisphosphate with a time course similar to that of cyclic GMP formation. In cells loaded with the fluorescent Ca2+ probe fura-2/acetoxymethyl ester, carbamylcholine as well as histamine induced a rapid and transient rise in [Ca2+]i. The time course of the changes in [Ca2+]i induced by agonists as well as by ionomycin closely paralleled that of cyclic GMP formation. Chelation of [Ca2+]i by loading of N1E-115 cells with quin 2/acetoxymethyl ester inhibited cyclic GMP formation induced by agonists in a dose-dependent manner. When cyclic GMP formation induced by agonists was assayed after the cells were exposed to 3 mM ethylene glycol bis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid (EGTA) for 2 min, the formation of cyclic GMP was not inhibited significantly; however, it was completely abolished after 30-min exposure to EGTA. Treatment of cells with phospholipase A2 had no effect on resting [Ca2+]i and only slightly increased cyclic GMP formation, in spite of the induction of a marked release of [3H]arachidonate. Moreover, the formation of cyclic GMP induced by ionomycin was inhibited by the addition of phospholipase A2. Melittin contaminated with phospholipase A2 activity induced a rapid and sustained increase in cyclic GMP formation, as well as unesterified [3H]arachidonate release. However, after inactivation of the phospholipase A2 activity of melittin, its ability to stimulate cyclic GMP formation was enhanced. Our data indicate that receptor agonists stimulate cyclic GMP formation in N1E-115 cells by activating the formation of inositol trisphosphate, which is followed by the release of Ca2+ from intracellular stores. The evidence obtained does not support a major role for arachidonate release in receptor-mediated activation of guanylate cyclase. Conversely, it is consistent with an inhibitory role for arachidonic acid or its metabolites in this process.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1972774

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  6 in total

1.  N-hydroxylamine is not an intermediate in the conversion of L-arginine to an activator of soluble guanylate cyclase in neuroblastoma N1E-115 cells.

Authors:  S Pou; W S Pou; G M Rosen; E E el-Fakahany
Journal:  Biochem J       Date:  1991-02-01       Impact factor: 3.857

2.  Regulation of neuronal nitric oxide synthase by histone, protamine, and myelin basic protein.

Authors:  J Hu; J Fridlund; E E el-Fakahany
Journal:  Neurochem Res       Date:  1995-04       Impact factor: 3.996

3.  Regulation of M1 muscarinic receptor-mediated signaling in intact cells by exogenous, but not endogenously produced, nitric oxide.

Authors:  A M Parsons; J L Sorman; E E El-Fakahany
Journal:  Neurochem Res       Date:  1999-01       Impact factor: 3.996

4.  Characterization of noradrenaline-stimulated cyclic GMP formation in brain astrocytes in culture.

Authors:  L Agulló; A García
Journal:  Biochem J       Date:  1992-12-01       Impact factor: 3.857

5.  Local positive feedback by calcium in the propagation of intracellular calcium waves.

Authors:  S S Wang; S H Thompson
Journal:  Biophys J       Date:  1995-11       Impact factor: 4.033

6.  The lifetime of inositol 1,4,5-trisphosphate in single cells.

Authors:  S S Wang; A A Alousi; S H Thompson
Journal:  J Gen Physiol       Date:  1995-01       Impact factor: 4.086

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.